193 related articles for article (PubMed ID: 20576629)
1. VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody.
Igawa T; Tsunoda H; Kikuchi Y; Yoshida M; Tanaka M; Koga A; Sekimori Y; Orita T; Aso Y; Hattori K; Tsuchiya M
Protein Eng Des Sel; 2010 Aug; 23(8):667-77. PubMed ID: 20576629
[TBL] [Abstract][Full Text] [Related]
2. The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody.
Lu D; Jimenez X; Witte L; Zhu Z
Biochem Biophys Res Commun; 2004 May; 318(2):507-13. PubMed ID: 15120630
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of a single-chain fragment of monoclonal antibody to ACE suitable for lung endothelial targeting.
Balyasnikova IV; Berestetskaya JV; Visintine DJ; Nesterovitch AB; Adamian L; Danilov SM
Microvasc Res; 2010 Dec; 80(3):355-64. PubMed ID: 20888351
[TBL] [Abstract][Full Text] [Related]
4. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
Nielsen UB; Adams GP; Weiner LM; Marks JD
Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
[TBL] [Abstract][Full Text] [Related]
5. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
6. [Cloning of the variable region genes from hybridoma against HAAH and then construction and expression of anti-HAAH scFv].
Wang H; Xue XP; Lei YF; Song K; Hu YT; Wang W; Yang H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):467-70. PubMed ID: 20423655
[TBL] [Abstract][Full Text] [Related]
7. Stability engineering of scFvs for the development of bispecific and multivalent antibodies.
Miller BR; Demarest SJ; Lugovskoy A; Huang F; Wu X; Snyder WB; Croner LJ; Wang N; Amatucci A; Michaelson JS; Glaser SM
Protein Eng Des Sel; 2010 Jul; 23(7):549-57. PubMed ID: 20457695
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
9. Integration of PEGylation and refolding for renaturation of recombinant proteins from insoluble aggregates produced in bacteria--application to a single-chain Fv fragment.
Kumagai I; Asano R; Nakanishi T; Hashikami K; Tanaka S; Badran A; Sanada H; Umetsu M
J Biosci Bioeng; 2010 May; 109(5):447-52. PubMed ID: 20347766
[TBL] [Abstract][Full Text] [Related]
10. A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody.
Rodríguez-Rodríguez ER; Ledezma-Candanoza LM; Contreras-Ferrat LG; Olamendi-Portugal T; Possani LD; Becerril B; Riaño-Umbarila L
J Mol Biol; 2012 Oct; 423(3):337-50. PubMed ID: 22835504
[TBL] [Abstract][Full Text] [Related]
11. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
[TBL] [Abstract][Full Text] [Related]
12. [New type recombinant antibody fragment scFv multimer and cancer targeting].
Guo J; Cai M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):361-5. PubMed ID: 12856620
[TBL] [Abstract][Full Text] [Related]
13. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
14. Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv.
Korn T; Nettelbeck DM; Völkel T; Müller R; Kontermann RE
J Gene Med; 2004 Jun; 6(6):642-51. PubMed ID: 15170735
[TBL] [Abstract][Full Text] [Related]
15. Improving the characteristics of a mycobacterial 16 kDa-specific chicken scFv.
Sixholo J; Van Wyngaardt W; Mashau C; Frischmuth J; Du Plessis DH; Fehrsen J
Biologicals; 2011 Mar; 39(2):110-6. PubMed ID: 21349739
[TBL] [Abstract][Full Text] [Related]
16. Towards a universal disulphide stabilised single chain Fv format: importance of interchain disulphide bond location and vL-vH orientation.
Weatherill EE; Cain KL; Heywood SP; Compson JE; Heads JT; Adams R; Humphreys DP
Protein Eng Des Sel; 2012 Jul; 25(7):321-9. PubMed ID: 22586154
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional analysis of recombinant scFv and diabody fragments with specificity for human RhD.
Asvadi P; Fletcher A; Raison RL
J Mol Recognit; 2002; 15(5):321-30. PubMed ID: 12447910
[TBL] [Abstract][Full Text] [Related]
18. A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency.
Duan Y; Gu TJ; Jiang CL; Yuan RS; Zhang HF; Hou HJ; Yu XH; Chen Y; Zhang Y; Wu YG; Kong W
Mol Immunol; 2012 Jun; 51(2):188-96. PubMed ID: 22484084
[TBL] [Abstract][Full Text] [Related]
19. Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers.
Arndt MA; Krauss J; Rybak SM
FEBS Lett; 2004 Dec; 578(3):257-61. PubMed ID: 15589829
[TBL] [Abstract][Full Text] [Related]
20. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
